Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
Primary Objective: To determine whether the Serious Illness Conversation Guide will improve the consistency with which providers have and document conversations regarding patients' goals and priorities as they near the end of life.
Secondary Objectives: 1. To assess whether having conversations as per this model will improve the quality of care near the end of life as determined by appropriate care in concordance with their goals of care.
2\. To assess whether having conversations as per this model will improve patient Quality of Life (QOL) as per a validated scale.
3\. To assess in patients with concordant care whether this model will improve patient QOL as per a validated scale 4. To assess provider opinions about end-of-life conversations.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with metastatic colorectal cancer whose tumor has progressed on both FOLFOX and FOLFIRI.
Exception: Patients with metastatic colorectal cancer whose tumors demonstrate a BRAF V600E mutation may be enrolled regardless of prior chemotherapy.
Exception: Patients whose tumors are MSI-H must have experience progression through immunotherapy in addition to the therapies mentioned above.
Patients with metastatic pancreatic adenocarcinoma.
Patients with metastatic gastric or esophageal cancer whose tumor has progressed through first-line chemotherapy of any type.
Patients with metastatic cholangiocarcinoma whose tumor has progressed through first-line chemotherapy of any type.
Patients with metastatic hepatocellular carcinoma whose tumor has progressed through PD1 blockade.
Patients with metastatic high-grade neuroendocrine tumor.
A patient with a metastatic GIST that has progressed through first-line tyrosine kinase inhibitor.
Expected life expectancy of at least one month
You may not be if
Any patient not meeting the above criteria
Non-English speaking patients
Clareo Health | Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
